The purpose of this research study is to see whether using atezolizumab before surgery is
safe and does not cause side effects that delay surgery in participants with cutaneous
melanoma that has not spread to other areas of the body (non-metastatic) and can be removed
by surgery (resectable) but has a higher risk of coming back after surgery (high-risk).
Phase:
Phase 1
Details
Lead Sponsor:
Ashley Holder, MD The Methodist Hospital Research Institute